PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cells
出版年份 2021 全文链接
标题
PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cells
作者
关键词
-
出版物
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 40, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-01-08
DOI
10.1186/s13046-020-01818-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Ipilimumab and Its Derived EGFR Aptamer-Based Conjugate Induce Efficient NK Cell Activation against Cancer Cells
- (2020) Margherita Passariello et al. Cancers
- SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-Dependent Tumors
- (2019) Tamer A. Ahmed et al. Cell Reports
- Targeting Alterations in the RAF–MEK Pathway
- (2019) Rona Yaeger et al. Cancer Discovery
- PD-1 Ligand Expression in Epithelial Thyroid Cancers: Potential Clinical Implications
- (2019) Salvatore Ulisse et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical development of targeted and immune based anti-cancer therapies
- (2019) N. A. Seebacher et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Combination of CTLA-4 and PD-1 blockers for treatment of cancer
- (2019) Anand Rotte JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Advances in cancer immunotherapy 2019 – latest trends
- (2019) Stephan Kruger et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer
- (2019) Francesca Collina et al. Cancers
- Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer
- (2019) Malfitano et al. Cancers
- The Immune Landscape of Cancer
- (2018) Vésteinn Thorsson et al. IMMUNITY
- Novel targeted therapies and immunotherapy for advanced thyroid cancers
- (2018) George E. Naoum et al. Molecular Cancer
- Neoadjuvant BRAF- and Immune-Directed Therapy for Anaplastic Thyroid Carcinoma
- (2018) Maria E. Cabanillas et al. THYROID
- Antigen-Presenting Cell-Intrinsic PD-1 Neutralizes PD-L1 in cis to Attenuate PD-1 Signaling in T Cells
- (2018) Yunlong Zhao et al. Cell Reports
- Shp-2 Is Dispensable for Establishing T Cell Exhaustion and for PD-1 Signaling In Vivo
- (2018) Giorgia Rota et al. Cell Reports
- Blockade of Tumor-Expressed PD-1 promotes lung cancer growth
- (2018) Shisuo Du et al. OncoImmunology
- Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma
- (2018) Priyanka C. Iyer et al. Journal for ImmunoTherapy of Cancer
- Cancer Cell-Intrinsic PD-1 and Implications in Combinatorial Immunotherapy
- (2018) Han Yao et al. Frontiers in Immunology
- Therapeutic advances in anaplastic thyroid cancer: a current perspective
- (2018) Shikha Saini et al. Molecular Cancer
- Programmed cell death-1 (PD-1) checkpoint blockade in combination with a mammalian target of rapamycin inhibitor restrains hepatocellular carcinoma growth induced by hepatoma cell-intrinsic PD-1
- (2017) Hui Li et al. HEPATOLOGY
- Expression of immunoregulatory molecules PD-L1 and PD-1 in oral cancer and precancerous lesions: A cohort study of Japanese patients
- (2017) Atsumu Kouketsu et al. JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
- Multiple anti-tumor effects of Reparixin on thyroid cancer
- (2017) Federica Liotti et al. Oncotarget
- Formyl peptide receptor 1 suppresses gastric cancer angiogenesis and growth by exploiting inflammation resolution pathways
- (2017) Nella Prevete et al. OncoImmunology
- Sticking It to Cancer with Molecular Glue for SHP2
- (2016) Hao Ran et al. CANCER CELL
- Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer
- (2016) Jill J. Bastman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
- (2016) Ying-Nan P. Chen et al. NATURE
- Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination
- (2016) Celine Boutros et al. Nature Reviews Clinical Oncology
- New structural and functional insight into the regulation of Ras
- (2016) Yoshihito Kano et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Interleukin-8, but Not the Related Chemokine CXCL1, Sustains an Autocrine Circuit Necessary for the Properties and Functions of Thyroid Cancer Stem Cells
- (2016) Federica Liotti et al. STEM CELLS
- Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth
- (2015) Sonja Kleffel et al. CELL
- Functions of Shp2 in cancer
- (2015) Jie Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Cancer immunotherapy: harnessing the immune system to battle cancer
- (2015) Yiping Yang JOURNAL OF CLINICAL INVESTIGATION
- Expression and clinical significance of tyrosine phosphatase SHP2 in thyroid carcinoma
- (2015) ZHONG-QIAN HU et al. Oncology Letters
- Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis
- (2015) Severa Bunda et al. Nature Communications
- The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis
- (2014) N Prevete et al. ONCOGENE
- Differentiated thyroid carcinomas and their B7H1 shield
- (2013) Lucas Leite Cunha et al. Future Oncology
- Cancer Immunotherapy
- (2013) M. McNutt SCIENCE
- Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma
- (2012) Lucas L. Cunha et al. CLINICAL ENDOCRINOLOGY
- Differentiated thyroid carcinomas may elude the immune system by B7H1 upregulation
- (2012) Lucas Leite Cunha et al. ENDOCRINE-RELATED CANCER
- Programmed Death-1+T Cells and Regulatory T Cells Are Enriched in Tumor-Involved Lymph Nodes and Associated with Aggressive Features in Papillary Thyroid Cancer
- (2012) Jena D. French et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Activation of TYRO3/AXL Tyrosine Kinase Receptors in Thyroid Cancer
- (2011) E. Avilla et al. CANCER RESEARCH
- The BRAFT1799A mutation confers sensitivity of thyroid cancer cells to the BRAFV600E inhibitor PLX4032 (RG7204)
- (2010) Joanna Xing et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Shp2 protein tyrosine phosphatase inhibitor activity of estramustine phosphate and its triterpenoid analogs
- (2010) Latanya M. Scott et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Protein tyrosine phosphatase SHP-2: A proto-oncogene product that promotes Ras activation
- (2009) Takashi Matozaki et al. CANCER SCIENCE
- Role of MAPK pathway oncoproteins in thyroid cancer pathogenesis and as drug targets
- (2009) Jeffrey A Knauf et al. CURRENT OPINION IN CELL BIOLOGY
- Different GPI-attachment signals affect the oligomerisation of GPI-anchored proteins and their apical sorting
- (2008) S. Paladino et al. JOURNAL OF CELL SCIENCE
- Thyroid carcinoma: molecular pathways and therapeutic targets
- (2008) Yuri E Nikiforov MODERN PATHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now